We recently co-hosted a webinar titled "Model-informed Drug Repurposing - Applications for COVID-19" with our colleagues at Certara.
During the webinar hosted by Adeniyi Olagunju, we covered the importance of integrating clinical pharmacology and translational medicine principles in COVID-19 dosing strategy and study design. Following this, Michael Dodds, Samer Mouksassi and Yuan Xiong from Certara demonstrated the pharmacokinetic pharmacodynamic (PKPD) simulation tools available on covidpharmacology.com using recently completed analyses for ivermectin, chloroquine, and lopinavir/ritonavir.
Thanks for joining us!
Length: 1hr 36m
Hosted on covidpharmacology.com Questions? Comments? Put them in the forum!